奥扎格雷钠,是目前高效强有力的血栓素合成酶抑制剂,是一种新型的抗血小板聚集药物。大庆让胡路区人民医院自2005-2007年应用奥扎格雷钠治疗急性脑梗死60例,取得较好疗效,现报告如下。1资料与方法1.1一般资料本组170例患者随机分为治疗组和对照组各60例。男48例,女12例,年龄48 Ozagrel sodium, a potent and effective thromboxane synthase inhibitor, is a novel anti-platelet aggregation drug. Daqing Rhu District People’s Hospital from 2005-2007 application of ozagrel sodium in the treatment of 60 cases of acute cerebral infarction, and achieved good results, are as follows. 1 Materials and Methods 1.1 General Information 170 patients in this group were randomly divided into treatment group and control group of 60 cases. 48 males and 12 females, age 48